Understanding antibodies to avoid pandemics
Structural biologist Pamela Björkman shared insights into pandemic viruses as part of the Department of Biology’s IAP seminar series.
Designing in a pandemic to fight a pandemic
The capstone senior design class in biological engineering, 20.380 (Biological Engineering Design), took on its most immediate challenge ever.
Model analyzes how viruses escape the immune system
Using this computational system, researchers can identify viral protein sequences that could make better vaccine targets.
Featured video: Covid-19 vaccines arrive at MIT
By the end of 2020, a first dose was administered to every at-risk staff member of MIT Medical who requested a vaccine.
3 Questions: Phillip Sharp on the discoveries that enabled mRNA vaccines for Covid-19
Curiosity-driven basic science in the 1970s laid the groundwork for today’s leading vaccines against the novel coronavirus.
Explained: Why RNA vaccines for Covid-19 raced to the front of the pack
Many years of research have enabled scientists to quickly synthesize RNA vaccines and deliver them inside cells.
3 Questions: Ram Sasisekharan on hastening vaccines and treatments
Biological engineer discusses condensing the time taken to develop therapeutics down from many years to a matter of months.
A step toward a universal flu vaccine
With computer models and lab experiments, researchers are working on a strategy for vaccines that could protect against any influenza virus.
Industry and scientific leaders examine Covid-19-era inequities, emphasize rapid testing
At MIT Forefront, panelists discuss health care and work during a pandemic — and the role for business where government falls short.
Syringe technology could enable injection of concentrated biologic drugs
Researchers have designed a simple, low-cost device for subcutaneous injection of viscous formulations.
SMART research enhances dengue vaccination in mice
Sequential immunization might be safer and more effective than the existing tetravalent vaccine.
Rapid antibody development yields possible treatment for yellow fever
The experimental drug has shown promise in early-stage clinical trials conducted in Singapore.
Engineers use “DNA origami” to identify vaccine design rules
In lab tests, virus-like DNA structures coated with viral proteins provoke a strong immune response in human B cells.
Improving global health equity by helping clinics do more with less
The startup macro-eyes uses artificial intelligence to improve vaccine delivery and patient scheduling.
How often do vaccine trials hit paydirt?
Study: Vaccines find more success in development than any other kind of drug, but have been relatively neglected in recent decades.